Medicaid/Husky

OHS committee chooses unrealistic cap for CT healthcare costs

By Ellen Andrews | June 22, 2020

The Office of Health Strategy’s (OHS) Technical Team choosing the cap for future Connecticut healthcare costs has decided on a…

Surprisingly, Medicaid applications are down sharply with the pandemic

By Ellen Andrews | June 20, 2020

At Friday’s MAPOC meeting, DSS reported that HUSKY applications were down 40% in May from a year before. This was…

Fact Check: Do lower Medicaid provider payment rates cause higher commercial payment rates?

By Ellen Andrews | June 11, 2020

Download this Fact Check There’s a pervasive myth that lower Medicaid provider payment rates force providers to charge private insurers…

Help for CT’s uninsured

By Ellen Andrews | June 10, 2020

With the recent spike in unemployment, many more Connecticut residents will be joining the thousands that were uninsured pre-COVID looking…

Cost Cap project could reduce access to care, stifle efficiency and innovation, and increase disparities

By Ellen Andrews | May 28, 2020

Download the Summary or Full Report Healthcare costs a lot in Connecticut, especially for middle and lower income residents. Primary…

Advocates, providers send Governor, legislators letter about cost cap impact and unintended consequences

By Ellen Andrews | May 28, 2020

Yesterday, twenty advocates and providers sent letters to the Governor and legislative leaders objecting to the rush to develop a…

CT Medical Society signs on with state HIE that plans to sell medical records

By Ellen Andrews | May 24, 2020

The state’s controversial HIE signed up its first participating provider network. Thursday the Office of Health Strategy (OHS) announced that…

CT hospitals would fare better than most if all payers used Medicare payment rates

By Ellen Andrews | May 13, 2020

A new study published in Health Affairs finds that if commercial payment rates were set at fee-for-service Medicare levels in…

Protecting affordability in a pandemic — Experts find fair prices for remdesivir between $10 and $4,500

By Ellen Andrews | May 5, 2020

In a nation hungry for good news in fighting the COVID-19 pandemic, remdesivir has emerged as a first ray of…